REQUEST A DEMO
Total
USD $0.00
Search more companies

Ryvu Therapeutics S.A. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology) | Medical Laboratories
Full name: Ryvu Therapeutics S.A. Profile Updated: March 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Polish Download a sample report

Ryvu Therapeutics S.A. is a company in Poland, with a head office in Krakow. The enterprise operates in the Research and Development in Biotechnology (except Nanobiotechnology) industry. The company was established on October 06, 2010. It currently has a total number of 101 - 500 (2024) employees. From the latest financial highlights, Ryvu Therapeutics S.A. reported a net sales revenue drop of 13.98% in 2025. Its’ total assets recorded a negative growth of 40.75%. The net profit margin of Ryvu Therapeutics S.A. decreased by 6.13% in 2025.

Headquarters
ul. Leona Sternbacha 2
Krakow; Malopolskie; Postal Code: 30-348

Contact Details: Purchase the Ryvu Therapeutics S.A. report to view the information.

Website: http://www.ryvu.com

Basic Information
Total Employees:
Purchase the Ryvu Therapeutics S.A. report to view the information.
Outstanding Shares:
Purchase the Ryvu Therapeutics S.A. report to view the information.
Registered Capital:
Purchase the Ryvu Therapeutics S.A. report to view the information.
Financial Auditors:
Purchase the Ryvu Therapeutics S.A. report to view the information.
Incorporation Date:
October 06, 2010
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
17.22%
Purchase this report to view the information.
9.22%
Purchase this report to view the information.
8.29%
Purchase this report to view the information.
5.99%
Purchase this report to view the information.
5.94%
Company Performance
Financial values in the chart are available after Ryvu Therapeutics S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-13.98%
Total Operating Revenue
-14.03%
Operating Profit
11.87%
EBITDA
12.04%
Net Profit/Loss for the Period
9.16%
Total Assets
-40.75%
Total Equity
-62.59%
Operating Profit Margin
-2.95%
Net Profit Margin
-6.13%
Return on Equity (ROE)
-110.59%
Debt / Equity
101.32%
Quick Ratio
-0.27%
Cash Ratio
-0.51%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?